- Home
- MGX vs BLNK Comparison
MGX vs BLNK Comparison
Compare MGX & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGX
- BLNK
- Stock Information
- Founded
- MGX 2018
- BLNK 2009
- Country
- MGX United States
- BLNK United States
- Employees
- MGX N/A
- BLNK N/A
- Industry
- MGX
- BLNK Industrial Specialties
- Sector
- MGX
- BLNK Consumer Discretionary
- Exchange
- MGX NYSE
- BLNK Nasdaq
- Market Cap
- MGX 150.1M
- BLNK 163.4M
- IPO Year
- MGX 2024
- BLNK N/A
- Fundamental
- Price
- MGX $2.61
- BLNK $1.47
- Analyst Decision
- MGX Strong Buy
- BLNK Buy
- Analyst Count
- MGX 7
- BLNK 7
- Target Price
- MGX $16.67
- BLNK $5.92
- AVG Volume (30 Days)
- MGX 1.0M
- BLNK 4.8M
- Earning Date
- MGX 02-12-2025
- BLNK 03-13-2025
- Dividend Yield
- MGX N/A
- BLNK N/A
- EPS Growth
- MGX N/A
- BLNK N/A
- EPS
- MGX N/A
- BLNK N/A
- Revenue
- MGX $55,080,000.00
- BLNK $138,728,000.00
- Revenue This Year
- MGX $16.91
- BLNK N/A
- Revenue Next Year
- MGX N/A
- BLNK $22.16
- P/E Ratio
- MGX N/A
- BLNK N/A
- Revenue Growth
- MGX 45.13
- BLNK 15.13
- 52 Week Low
- MGX $1.61
- BLNK $1.38
- 52 Week High
- MGX $12.74
- BLNK $3.75
- Technical
- Relative Strength Index (RSI)
- MGX 39.42
- BLNK 43.37
- Support Level
- MGX $2.67
- BLNK $1.41
- Resistance Level
- MGX $4.06
- BLNK $1.58
- Average True Range (ATR)
- MGX 0.31
- BLNK 0.10
- MACD
- MGX -0.16
- BLNK -0.00
- Stochastic Oscillator
- MGX 2.62
- BLNK 20.45
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.